Orforglipron, Placebo to match LY3502970
JAM-MC-PWMP, -PW01
Phase 3 small_molecule active
Quick answer
Orforglipron, Placebo to match LY3502970 for Obesity, Overweight is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Obesity, Overweight
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active